Copyright Reports & Markets. All rights reserved.

Global Post herpetic Neuralgia Treatment Market Size, Status and Forecast 2019-2025

Request for Sample of this report
Buy now

Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Key Market Segments
    • 1.3 Players Covered
    • 1.4 Market Analysis by Type
      • 1.4.1 Global Post herpetic Neuralgia Treatment Market Size Growth Rate by Type (2014-2025)
      • 1.4.2 Anticonvulsants
      • 1.4.3 Skin Patch
      • 1.4.4 Other
    • 1.5 Market by Application
      • 1.5.1 Global Post herpetic Neuralgia Treatment Market Share by Application (2014-2025)
      • 1.5.2 Hospital Pharmacies
      • 1.5.3 Online Pharmacies
      • 1.5.4 Retail Pharmacies
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Global Growth Trends

    • 2.1 Post herpetic Neuralgia Treatment Market Size
    • 2.2 Post herpetic Neuralgia Treatment Growth Trends by Regions
      • 2.2.1 Post herpetic Neuralgia Treatment Market Size by Regions (2014-2025)
      • 2.2.2 Post herpetic Neuralgia Treatment Market Share by Regions (2014-2019)
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers
      • 2.3.3 Market Challenges
      • 2.3.4 Porter’s Five Forces Analysis

    3 Market Share by Key Players

    • 3.1 Post herpetic Neuralgia Treatment Market Size by by Players
      • 3.1.1 Global Post herpetic Neuralgia Treatment Revenue by by Players (2014-2019)
      • 3.1.2 Global Post herpetic Neuralgia Treatment Revenue Market Share by by Players (2014-2019)
      • 3.1.3 Global Post herpetic Neuralgia Treatment Market Concentration Ratio (CR5 and HHI)
    • 3.2 Post herpetic Neuralgia Treatment Key Players Head office and Area Served
    • 3.3 Key Players Post herpetic Neuralgia Treatment Product/Solution/Service
    • 3.4 Date of Enter into Post herpetic Neuralgia Treatment Market
    • 3.5 Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Type and Application

    • 4.1 Global Post herpetic Neuralgia Treatment Market Size by Type (2014-2019)
    • 4.2 Global Post herpetic Neuralgia Treatment Market Size by Application (2014-2019)

    5 United States

    • 5.1 United States Post herpetic Neuralgia Treatment Market Size (2014-2019)
    • 5.2 Post herpetic Neuralgia Treatment Key Players in United States
    • 5.3 United States Post herpetic Neuralgia Treatment Market Size by Type
    • 5.4 United States Post herpetic Neuralgia Treatment Market Size by Application

    6 Europe

    • 6.1 Europe Post herpetic Neuralgia Treatment Market Size (2014-2019)
    • 6.2 Post herpetic Neuralgia Treatment Key Players in Europe
    • 6.3 Europe Post herpetic Neuralgia Treatment Market Size by Type
    • 6.4 Europe Post herpetic Neuralgia Treatment Market Size by Application

    7 China

    • 7.1 China Post herpetic Neuralgia Treatment Market Size (2014-2019)
    • 7.2 Post herpetic Neuralgia Treatment Key Players in China
    • 7.3 China Post herpetic Neuralgia Treatment Market Size by Type
    • 7.4 China Post herpetic Neuralgia Treatment Market Size by Application

    8 Japan

    • 8.1 Japan Post herpetic Neuralgia Treatment Market Size (2014-2019)
    • 8.2 Post herpetic Neuralgia Treatment Key Players in Japan
    • 8.3 Japan Post herpetic Neuralgia Treatment Market Size by Type
    • 8.4 Japan Post herpetic Neuralgia Treatment Market Size by Application

    9 Southeast Asia

    • 9.1 Southeast Asia Post herpetic Neuralgia Treatment Market Size (2014-2019)
    • 9.2 Post herpetic Neuralgia Treatment Key Players in Southeast Asia
    • 9.3 Southeast Asia Post herpetic Neuralgia Treatment Market Size by Type
    • 9.4 Southeast Asia Post herpetic Neuralgia Treatment Market Size by Application

    10 India

    • 10.1 India Post herpetic Neuralgia Treatment Market Size (2014-2019)
    • 10.2 Post herpetic Neuralgia Treatment Key Players in India
    • 10.3 India Post herpetic Neuralgia Treatment Market Size by Type
    • 10.4 India Post herpetic Neuralgia Treatment Market Size by Application

    11 Central & South America

    • 11.1 Central & South America Post herpetic Neuralgia Treatment Market Size (2014-2019)
    • 11.2 Post herpetic Neuralgia Treatment Key Players in Central & South America
    • 11.3 Central & South America Post herpetic Neuralgia Treatment Market Size by Type
    • 11.4 Central & South America Post herpetic Neuralgia Treatment Market Size by Application

    12 International Players Profiles

    • 12.1 Pfizer
      • 12.1.1 Pfizer Company Details
      • 12.1.2 Company Description and Business Overview
      • 12.1.3 Post herpetic Neuralgia Treatment Introduction
      • 12.1.4 Pfizer Revenue in Post herpetic Neuralgia Treatment Business (2014-2019)
      • 12.1.5 Pfizer Recent Development
    • 12.2 Arbor Pharma
      • 12.2.1 Arbor Pharma Company Details
      • 12.2.2 Company Description and Business Overview
      • 12.2.3 Post herpetic Neuralgia Treatment Introduction
      • 12.2.4 Arbor Pharma Revenue in Post herpetic Neuralgia Treatment Business (2014-2019)
      • 12.2.5 Arbor Pharma Recent Development
    • 12.3 Assertio Therapeutics
      • 12.3.1 Assertio Therapeutics Company Details
      • 12.3.2 Company Description and Business Overview
      • 12.3.3 Post herpetic Neuralgia Treatment Introduction
      • 12.3.4 Assertio Therapeutics Revenue in Post herpetic Neuralgia Treatment Business (2014-2019)
      • 12.3.5 Assertio Therapeutics Recent Development
    • 12.4 Endo Pharma
      • 12.4.1 Endo Pharma Company Details
      • 12.4.2 Company Description and Business Overview
      • 12.4.3 Post herpetic Neuralgia Treatment Introduction
      • 12.4.4 Endo Pharma Revenue in Post herpetic Neuralgia Treatment Business (2014-2019)
      • 12.4.5 Endo Pharma Recent Development
    • 12.5 Teikoku Pharma
      • 12.5.1 Teikoku Pharma Company Details
      • 12.5.2 Company Description and Business Overview
      • 12.5.3 Post herpetic Neuralgia Treatment Introduction
      • 12.5.4 Teikoku Pharma Revenue in Post herpetic Neuralgia Treatment Business (2014-2019)
      • 12.5.5 Teikoku Pharma Recent Development
    • 12.6 Teva
      • 12.6.1 Teva Company Details
      • 12.6.2 Company Description and Business Overview
      • 12.6.3 Post herpetic Neuralgia Treatment Introduction
      • 12.6.4 Teva Revenue in Post herpetic Neuralgia Treatment Business (2014-2019)
      • 12.6.5 Teva Recent Development
    • 12.7 Mylan
      • 12.7.1 Mylan Company Details
      • 12.7.2 Company Description and Business Overview
      • 12.7.3 Post herpetic Neuralgia Treatment Introduction
      • 12.7.4 Mylan Revenue in Post herpetic Neuralgia Treatment Business (2014-2019)
      • 12.7.5 Mylan Recent Development
    • 12.8 Hengrui Medicine
      • 12.8.1 Hengrui Medicine Company Details
      • 12.8.2 Company Description and Business Overview
      • 12.8.3 Post herpetic Neuralgia Treatment Introduction
      • 12.8.4 Hengrui Medicine Revenue in Post herpetic Neuralgia Treatment Business (2014-2019)
      • 12.8.5 Hengrui Medicine Recent Development

    13 Market Forecast 2019-2025

    • 13.1 Market Size Forecast by Regions
    • 13.2 United States
    • 13.3 Europe
    • 13.4 China
    • 13.5 Japan
    • 13.6 Southeast Asia
    • 13.7 India
    • 13.8 Central & South America
    • 13.9 Market Size Forecast by Product (2019-2025)
    • 13.10 Market Size Forecast by Application (2019-2025)

    14 Analyst's Viewpoints/Conclusions

      15 Appendix

      • 15.1 Research Methodology
        • 15.1.1 Methodology/Research Approach
          • 15.1.1.1 Research Programs/Design
          • 15.1.1.2 Market Size Estimation
          • 12.1.1.3 Market Breakdown and Data Triangulation
        • 15.1.2 Data Source
          • 15.1.2.1 Secondary Sources
          • 15.1.2.2 Primary Sources
      • 15.2 Disclaimer

      Post herpetic neuralgia is a painful condition that can occur after having shingles, a complication of chicken pox. The goal of therapy for post herpetic neuralgia is to reduce morbidity through the use of tricyclic antidepressants, anticonvulsants, anesthetics, analgesics, corticosteroids and antiviral agents.
      The classification of Post herpetic Neuralgia Treatment includes Anticonvulsants, Skin Patch and others, and the proportion of Anticonvulsants in 2018 is about 81.7%.
      Post herpetic Neuralgia Treatment is widely used for Hospital Pharmacies, Online Pharmacies and Retail Pharmacies. The Hospital Pharmacies is major application it accounts for about 52% market share in 2018.
      In 2018, the global Post herpetic Neuralgia Treatment market size was 1413 million US$ and it is expected to reach 1854.4 million US$ by the end of 2025, with a CAGR of 4.0% during 2019-2025.

      This report focuses on the global Post herpetic Neuralgia Treatment status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Post herpetic Neuralgia Treatment development in United States, Europe and China.

      The key players covered in this study
      Pfizer
      Arbor Pharma
      Assertio Therapeutics
      Endo Pharma
      Teikoku Pharma
      Teva
      Mylan
      Hengrui Medicine

      Market segment by Type, the product can be split into
      Anticonvulsants
      Skin Patch
      Other

      Market segment by Application, split into
      Hospital Pharmacies
      Online Pharmacies
      Retail Pharmacies

      Market segment by Regions/Countries, this report covers
      United States
      Europe
      China
      Japan
      Southeast Asia
      India
      Central & South America

      The study objectives of this report are:
      To analyze global Post herpetic Neuralgia Treatment status, future forecast, growth opportunity, key market and key players.
      To present the Post herpetic Neuralgia Treatment development in United States, Europe and China.
      To strategically profile the key players and comprehensively analyze their development plan and strategies.
      To define, describe and forecast the market by product type, market and key regions.

      In this study, the years considered to estimate the market size of Post herpetic Neuralgia Treatment are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025
      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

      Buy now